The PI3K/AKT Pathway as a Target for Cancer Treatment

被引：635
|
作者：
Mayer, Ingrid A. [1 ,2 ,3 ]
Arteaga, Carlos L. [1 ,2 ,3 ]
机构：
[1] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Sch Med, Breast Canc Program, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA
来源：
ANNUAL REVIEW OF MEDICINE, VOL 67 | 2016年 / 67卷
关键词：
phosphoinositide 3-kinase (PI3K)/AKT; mammalian target of rapamycin (mTOR); pathway inhibitors; breast cancer; lymphoproliferative disorders; mutation; CHRONIC LYMPHOCYTIC-LEUKEMIA; POSITIVE BREAST-CANCER; RENAL-CELL CARCINOMA; PIK3CA MUTATIONS; PHOSPHOINOSITIDE; 3-KINASE; PHOSPHATIDYLINOSITOL; ESTROGEN DEPRIVATION; TYROSINE KINASE; MAMMARY-TUMORS; UP-REGULATION;
D O I：
10.1146/annurev-med-062913-051343
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Anticancer targeted therapies are designed to exploit a particular vulnerability in the tumor, which in most cases results from its dependence on an oncogene and/or loss of a tumor suppressor. Genes in the phosphoinositide 3-kinase (PI3K)/AKT pathway are the most frequently altered in human cancers. Aberrant activation of this pathway, as a result of these somatic alterations, is associated with cellular transformation, tumorigenesis, cancer progression, and drug resistance. Several drugs targeting PI3K/ATK are currently in clinical trials, alone or in combination, in both solid tumors and hematologic malignancies. These drugs are the focus of this review.
引用
收藏
页码：11 / 28
页数：18
相关论文
共 50 条
  • [31] Targeting the PI3K/AKT/mTOR pathway in ovarian cancer
    Musa, Fernanda
    Schneider, Robert
    TRANSLATIONAL CANCER RESEARCH, 2015, 4 (01) : 97 - 106
  • [32] MicroRNAs and the PTEN/PI3K/Akt pathway in gastric cancer
    Hu, Mingli
    Zhu, Shixuan
    Xiong, Shengwei
    Xue, Xingxing
    Zhou, Xiaodong
    ONCOLOGY REPORTS, 2019, 41 (03) : 1439 - 1454
  • [33] The PI3K/Akt/mTOR pathway:: a new therapeutic target in the treatment of acute myeloid leukemia
    Dos Santos, Cedric
    Recher, Christian
    Demur, Cecile
    Payrastre, Bernard
    BULLETIN DU CANCER, 2006, 93 (05) : 445 - 447
  • [34] Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic Cancer
    Totiger, Tulasigeri M.
    Srinivasan, Supriya
    Jala, Venkatakrishna R.
    Lamichhane, Purushottam
    Dosch, Austin R.
    Gaidarski, Alexander A., III
    Joshi, Chandrashekhar
    Rangappa, Shobith
    Castellanos, Jason
    Vemula, Praveen Kumar
    Chen, Xi
    Kwon, Deukwoo
    Kashikar, Nilesh
    VanSaun, Michael
    Merchant, Nipun B.
    Nagathihalli, Nagaraj S.
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (02) : 301 - 311
  • [35] Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer
    Chen, Jiezhong
    Zhao, Kong-Nan
    Li, Rui
    Shao, Renfu
    Chen, Chen
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (26) : 3070 - 3080
  • [36] Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis
    Giacoppo, Sabrina
    Pollastro, Federica
    Grassi, Gianpaolo
    Bramanti, Placido
    Mazzon, Emanuela
    FITOTERAPIA, 2017, 116 : 77 - 84
  • [37] The role of ubiquitination and deubiquitination in PI3K/AKT/mTOR pathway: A potential target for cancer therapy
    Jin, Jiabei
    He, Jian
    Li, Xinming
    Ni, Xiaoqi
    Jin, Xiaofeng
    GENE, 2023, 889
  • [38] PI3K/AKT/mTOR Pathway in Ovarian Cancer Treatment: Are We on the Right Track?
    Gasparri, Maria Luisa
    Bardhi, Erlisa
    Ruscito, Ilary
    Papadia, Andrea
    Farooqi, Ammad Ahmad
    Marchetti, Claudia
    Bogani, Giorgio
    Ceccacci, Irene
    Mueller, Michael D.
    Panici, Pierluigi Benedetti
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2017, 77 (10) : 1095 - 1103
  • [39] Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance
    Chang, Lei
    Graham, Peter H.
    Ni, Jie
    Hao, Jingli
    Bucci, Joseph
    Cozzi, Paul J.
    Li, Yong
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 96 (03) : 507 - 517
  • [40] The versatile role of curcumin in cancer prevention and treatment: A focus on PI3K/AKT pathway
    Hamzehzadeh, Leila
    Atkin, Stephen L.
    Majeed, Muhammed
    Butler, Alexandra E.
    Sahebkar, Amirhossein
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (10) : 6530 - 6537
12345